Stay updated on Grapiprant and Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Grapiprant and Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Grapiprant and Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, indicating a new release version. This update is an internal version change and does not modify the study content.
    Difference
    0.1%
    Check dated 2026-08-29T21:50:34.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Core page content identifying investigators, sponsor, collaborators, and other study personnel was removed, along with multiple study record metadata sections. A new Revision: v3.6.5 tag appears, indicating a version update to the page.
    Difference
    17%
    Check dated 2026-08-08T18:14:23.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page's revision version was updated from v3.6.3 to v3.6.4, indicating a new deployment. This update does not modify the study details or functionality presented to users.
    Difference
    0.1%
    Check dated 2026-07-25T12:29:54.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page version was updated from v3.6.2 to v3.6.3. This represents a routine update that does not alter study information or how a user interacts with the page.
    Difference
    0.1%
    Check dated 2026-07-03T22:55:39.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.2, replacing the previous Revision: v3.6.0; this indicates a new build of the page template rather than substantive changes to the study information.
    Difference
    0.1%
    Check dated 2026-06-27T01:49:45.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    A recruitment status line indicating no participant enrollment was added. Additionally, new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Interventional label formatting was refined from 'Intervention / Treatment' to 'Intervention/Treatment', and a site revision stamp 'Revision: v3.6.0' was introduced.
    Difference
    0.6%
    Check dated 2026-06-12T16:11:36.000Z thumbnail image

Stay in the know with updates to Grapiprant and Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Grapiprant and Pembrolizumab in NSCLC Clinical Trial page.